At Angiolife Healthcare , we accept nothing but the highest attainable quality and safety standards and demand the same high standards of our suppliers and distributors.
Our standards are maintained through strict policies and procedures. These procedures are carefully implemented and are applicable throughout the lifecycle of the product, from development to commercialization.
The company is assessed regularly by the Agency to ensure that Angiolife Healthcare is certified to be registered in the list of Registered Organizations with regard to the Standard and scope of supply. GMP is the regulatory regime all pharmaceuticals manufacturers must comply with to ensure that the finished products possess the requisite identity, strength, quality, and purity and to ensure the safety of the patients.
All manufacturers with whom Angiolife Healthcare cooperates are carefully inspected by Angiolife Healthcare quality assurance division at regular intervals to ensure compliance for pharmaceuticals manufacturing. The company's manufacturers must be licensed by the Indian Medicines Agency and are inspected by that agency regularly.
Finally, the company's QP releases the pharmaceutical product for sale. The release is conditional on all analysis results meeting specifications and on the pharmaceutical having been manufactured, packaged and tested in accordance with GMP requirements and the approved marketing authorization.
Angiolife Healthcare Pharmacovigilance team is responsible for monitoring, identifying, analyzing and reporting potential safety risks. The team actively reviews patient safety experiences, and uses an advanced database that allows for effective collection, assessment and prevention of adverse events.
We are continuously monitored by regulatory authorities. As a marketing licence holder the company must meet the requirement of monitoring the safety of the products approved for use on the world market.
Angiolife Healthcare complies with all environmental legislation and requirements currently governing pharmaceuticals manufacturing. Consequently, the company verifies that manufacturers hold environmental permits and ensures that the results of analyses from test samples meet the requirements stipulated in environmental permits. In addition, Angiolife Healthcare verifies that the manufacturers analyse the water which leaves their plants for traces of pharmaceutical substances and Angiolife Healthcare scrutinises the way in which manufacturers handle their waste.
Angiolife Healthcare ambition is to constantly improve its work on environmental issues and Angiolife Healthcare carefully monitors the areas on the agenda of public agencies.